RTW INVESTMENTS, LP

Position in QURE — uniQure N.V.

CIK 1493215 NEW YORK, NY

Position in QURE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$42,286,920

-$46,528,365 QoQ

Shares Held

2,586,356

-30.3% QoQ

Ownership

4.10%

of shares outstanding

% of Portfolio

0.42%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

RTW INVESTMENTS, LP holds $8,256,157,304 across 64 Biotechnology names. QURE ranks #34 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MDGL	Madrigal Pharmaceuticals, Inc.	1,993,687	$1,043,635,333
2	INSM	INSMED Inc	4,842,880	$791,907,737
3	PTGX	Protagonist Therapeutics, Inc	5,059,053	$533,224,186
4	PTCT	Ptc Therapeutics, Inc.	7,746,415	$527,763,253
5	ARGX	Argenx SE	709,446	$518,072,941
6	CGON	CG Oncology, Inc.	6,984,808	$472,731,805
7	CELC	Celcuity Inc.	3,039,621	$346,942,340
8	TNGX	Tango Therapeutics, Inc.	13,300,620	$278,248,970

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$42,286,920	2,586,356	-30.3%	Shares	Sole	2026-05-15
2025-12-31	$88,815,285	3,711,462	0.0%	Shares	Sole	2026-02-17
2025-12-31	$88,815,285	3,711,462	-16.1%	Shares	Sole	2026-02-17
2025-09-30	$258,285,382	4,424,968	-14.2%	Shares	Sole	2025-11-14
2025-06-30	$71,905,740	5,158,231	+20.9%	Shares	Sole	2025-08-14
2025-03-31	$45,213,536	4,265,428	+372.0%	Shares	Sole	2025-05-15
2024-12-31	$15,958,017	903,625	+8936.2%	Shares	Sole	2025-02-14
2024-09-30	$49,300	10,000	-93.7%	Shares	Sole	2024-11-14
2020-09-30	$5,836,781	158,479	+0.8%	Shares	Sole	2020-11-16
2020-06-30	$7,087,126	157,282	+0.8%	Shares	Sole	2020-08-14
2020-03-31	$7,405,806	156,076	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.